APA

Rowley M., Broughton H. B., Collins I., Baker R., Emms F., Marwood R., Patel S., Patel S., Ragan C. I., Freedman S. B. & Leeson P. D. (19960718). 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors. : Journal of medicinal chemistry.

Chicago

Rowley M, Broughton H B, Collins I, Baker R, Emms F, Marwood R, Patel S, Patel S, Ragan C I, Freedman S B and Leeson P D. 19960718. 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors. : Journal of medicinal chemistry.

Harvard

Rowley M., Broughton H. B., Collins I., Baker R., Emms F., Marwood R., Patel S., Patel S., Ragan C. I., Freedman S. B. and Leeson P. D. (19960718). 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors. : Journal of medicinal chemistry.

MLA

Rowley M, Broughton H B, Collins I, Baker R, Emms F, Marwood R, Patel S, Patel S, Ragan C I, Freedman S B and Leeson P D. 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors. : Journal of medicinal chemistry. 19960718.